During this period of time, 2 (1.2%) RA-FDRs became anti-CCP2 positive, none developed anti-CCP3 IgG positivity, 6 (3.6%) became RF IgM positive and 1 (0.6%) RF IgA positive (Table 2). The gene discussed is AGBL2; the disease is rheumatoid arthritis.